Prevalence of silent coronary artery disease among patients with type 2 diabetes mellitus in Suleimani, Iraq
DOI:
https://doi.org/10.22317/imj.v6i2.1174Keywords:
Coronary Artery Disease, Type 2 Diabetes Mellitus, Silent ischemia, ElectrocardiographyAbstract
Objective: To study the prevalence of silent coronary artery disease among patients with Type 2 Diabetes Mellitus and associated variables.
Methods: A cross sectional multi-center design study in the Sulaymaniyah city. The data collected from patients admitted to medical wards of Shar teaching Hospital, Shahid Hemn teaching Hospital and Faruq medical city. It was conducted during the period of 10 months starting from April, 2017 to Jan, 2018. All patients with type 2 Diabetes Mellitus without symptoms of coronary heart disease were included. Symptoms were evaluated by history, physical examination including blood pressure measurement and searching for other risk factors. The patients were investigated for HbA1c, Lipid profile, resting Electrocardiography (ECG), Echocardiography, Exercise Treadmill test, and CT coronary angiography.
Results: A total of 106 patients, 55 male (51.9%) and 51 female (48.1%) were enrolled in this study, the mean age of the patients was (58.50yr ± 10.94), Nine(8.4%) patients had ischemic change by resting ECG, 10 (9.4%) had ischemic change by Echocardiography, Exercise treadmill test (ETT) was done for 20 patients and revealed positivity for ischemia in only 3(15%) patients, CT coronary angiography was done for three patients and were conclusive for CAD.
Conclusion: Silent coronary artery disease is common in patients with type 2 diabetes mellitus, therefore patients with DM should be carefully evaluated to detect early cardiovascular adverse effect to avoid fatal consequences.
References
Chiha M, Njeim M, Chedrawy EG. Diabetes and Coronary Heart Disease: A Risk Factor for the Global Epidemic. Int J Hypertens. 2012; 2012:1–7.
Rutter MK, Nesto RW. The changing costs and benefits of screening for asymptomatic coronary heart disease in patients with diabetes. Nat Clin Pract Endocrinol Metab. 2007 Jan; 3(1):26–35.
Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham study. Circulation. 1979; 59(1):8–13.
O’Rourke RA. Should patients with type 2 diabetes asymptomatic for coronary artery disease undergo testing for myocardial ischemia? Nat Clin Pract Cardiovasc Med. 2005 Oct; 2(10):492–3.
Cook SA, Aitman T, Naoumova RP. Therapy Insight: heart disease and the insulin-resistant patient. Nat Clin Pract Cardiovasc Med. 2005 May; 2(5):252–60.
Kasper DL, editor. Harrison’s principles of internal medicine. 19th edition / editors, Dennis L. Kasper, MD, William Ellery Channing, Professor of Medicine, Professor of Microbiology, Department of Microbiology and Immunobiology, Harvard Medical School, Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts [and five others]. New York: McGraw Hill Education; 2015. 1 p.
Conti CR, Bavry AA, Petersen JW. Silent Ischemia. J Am Coll Cardiol. 2012 Jan; 59(5):435–41.
Schang SJ, Pepine CJ. Transient asymptomatic S-T segment depression during daily activity. Am J Cardiol. 1977 Mar; 39 (3):396–402.
Fleg JL. Prevalence and prognostic significance of exercise-induced silent myocardial ischemia in apparently healthy subjects. Am J Cardiol. 1992 Mar 6; 69 (7):14B-18B.
Zellweger MJ, Pfisterer ME. Silent coronary artery disease in patients with diabetes mellitus. Swiss Med Wkly. 2001 Jul 28; 131(29–30):427–32.
Tavares CAF, Wajchjenberg BL, Rochitte C, Lerario AC. Screening for asymptomatic coronary artery disease in patients with type 2 diabetes mellitus. Arch Endocrinol Metab. 2016 Apr; 60(2):143–51.
Scognamiglio R, Negut C, Ramondo A, Tiengo A, Avogaro A. Detection of Coronary Artery Disease in Asymptomatic Patients With Type 2 Diabetes Mellitus. J Am Coll Cardiol. 2006 Jan; 47(1):65–71.
MD AM. Ischemic Heart Disease: A Rational Basis for Clinical Practise and Clinical Research, 1e. New York: Churchill Livingstone; 1995. 725 p.
Cohn PF. Silent myocardial ischemia: classification, prevalence, and prognosis. Am J Med. 1985 Sep 13; 79(3A):2–6?
Droste C, Roskamm H. Silent myocardial ischemia. Am Heart J. 1989 Nov 1; 118(5, Part 2):1087–92.
Mannheimer C. The problem of chronic refractory angina. Report from the ESC Joint Study Group on the Treatment of Refractory Angina. Eur Heart J. 2002 Mar 1; 23(5):355–70.
Huang L, Zhu S. [The role of beta-endorphin and pain perception in silent myocardial ischemia]. Zhonghua Xin Xue Guan Bing Za Zhi. 1991 Feb; 19 (1):3–6, 63.
Airaksinen KE. Silent coronary artery disease in diabetes--a feature of autonomic neuropathy or accelerated atherosclerosis? Diabetologia. 2001 Feb; 44 (2):259–66.
Alexander CM, Landsman PB, Teutsch SM. Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors, and prevalence of coronary heart disease. Am J Cardiol. 2000 Nov 1; 86(9):897–902.
Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in noninsulin-dependent diabetes mellitus. Milan Study on Atherosclerosis and Diabetes (MiSAD) Group. Am J Cardiol. 1997 Jan 15; 79(2):134–9.
Fornengo P, Bosio A, Epifani G, Pallisco O, Mancuso A, Pascale C. Prevalence of silent myocardial ischaemia in new-onset middle-aged Type 2 diabetic patients without other cardiovascular risk factors. Diabet Med J Br Diabet Assoc. 2006 Jul; 23(7):775–9.
al SS et. Six-year follow-up of a cohort of 203 patients with diabetes after screening for silent myocardial ischaemia. - PubMed - NCBI [Internet]. [Cited 2018 Mar 16]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/17054593
Ditchburn CJ, Hall JA, de Belder M, Davies A, Kelly W, Bilous R. Silent myocardial ischaemia in patients with proved coronary artery disease: a comparison of diabetic and non-diabetic patients. Postgrad Med J. 2001 Jun; 77 (908):395–8.
DeLuca AJ, Saulle LN, Aronow WS, Ravipati G, Weiss MB. Prevalence of silent myocardial ischemia in persons with diabetes mellitus or impaired glucose tolerance and association of hemoglobin A1C with prevalence of silent myocardial ischemia. Am J Cardiol. 2005 Jun 15; 95 (12):1472–4.
Janand-Delenne B, Savin B, Habib G, Bory M, Vague P, Lassmann-Vague V. Silent myocardial ischemia in patients with diabetes: who to screen. Diabetes Care. 1999 Sep; 22 (9):1396–400.
Inoguchi T, Yamashita T, Umeda F, Mihara H, Nakagaki O, Takada K, et al. High incidence of silent myocardial ischemia in elderly patients with non insulin-dependent diabetes mellitus. Diabetes Res Clin Pract. 2000 Jan; 47(1):37–44.